Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CORBF Global Cord Blood	$0.55 -59.3%	$1.02	$0.25 ▼ $2.00	$66.85M	-0.6	101,623 shs	100 shs
DVCR Diversicare Healthcare Services	$10.09 +1.0%	$10.09	$2.50 ▼ $10.09	$70.12M	0.86	18,931 shs	49,400 shs
VMD Viemed Healthcare	$7.42 +1.8%	$6.69	$5.93 ▼ $9.81	$287.82M	1.33	170,915 shs	212,818 shs
XGN Exagen	$9.46 +0.9%	$7.45	$2.38 ▼ $9.54	$208.89M	1.61	228,448 shs	131,746 shs

These 7 Stocks Will Be Magnificent in 2025

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CORBF Global Cord Blood	0.00%	+90.14%	+80.00%	+28.57%	-22.86%
DVCR Diversicare Healthcare Services	0.00%	0.00%	0.00%	0.00%	0.00%
VMD Viemed Healthcare	+2.68%	+20.10%	+8.16%	+5.81%	+0.41%
XGN Exagen	+1.96%	+5.99%	+34.19%	+66.61%	+177.51%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
CORBF Global Cord Blood	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
DVCR Diversicare Healthcare Services	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
VMD Viemed Healthcare	2.7457 of 5 stars	0.0	5.0	0.0	0.0	2.5	3.3	1.3
XGN Exagen	4.2813 of 5 stars	3.5	2.0	0.0	4.5	3.1	2.5	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CORBF Global Cord Blood	0.00	N/A	N/A	N/A
DVCR Diversicare Healthcare Services	0.00	N/A	N/A	N/A
VMD Viemed Healthcare	0.00	N/A	N/A	N/A
XGN Exagen	3.00	Buy	$11.25	18.92% Upside

Current Analyst Ratings Breakdown

Latest DVCR, VMD, XGN, and CORBF Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/30/2025	XGN Exagen	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$10.00
7/30/2025	XGN Exagen	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$8.00 ➝ $11.00
7/30/2025	XGN Exagen	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Sector Weight ➝ Overweight	$12.00
7/23/2025	XGN Exagen	Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$12.00
5/15/2025	XGN Exagen	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight
5/15/2025	XGN Exagen	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$8.00 ➝ $7.00
5/13/2025	XGN Exagen	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$7.00 ➝ $8.00

(Data available from 8/12/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CORBF Global Cord Blood	$196.12M	0.34	$0.39 per share	1.40	N/A	∞
DVCR Diversicare Healthcare Services	$475.72M	0.15	$5.87 per share	1.72	($4.57) per share	-2.21
VMD Viemed Healthcare	$224.26M	1.28	$0.98 per share	7.55	$3.41 per share	2.18
XGN Exagen	$55.64M	3.74	N/A	N/A	$0.54 per share	17.52

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CORBF Global Cord Blood	$79.04M	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
DVCR Diversicare Healthcare Services	$5.16M	$0.36	28.03	∞	N/A	0.53%	-15.01%	1.05%	N/A
VMD Viemed Healthcare	$11.27M	$0.34	21.82	∞	N/A	5.80%	10.38%	7.88%	N/A
XGN Exagen	-$15.11M	-$0.89	N/A	N/A	N/A	-28.85%	-130.38%	-34.69%	N/A

Latest DVCR, VMD, XGN, and CORBF Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/6/2025	Q2 2025	VMD Viemed Healthcare	$0.0850	$0.08	-$0.0050	$0.08	$63.50 million	$63.06 million
7/29/2025	Q2 2025	XGN Exagen	-$0.18	-$0.18	N/A	-$0.21	$16.25 million	$17.20 million
5/12/2025	Q1 2025	XGN Exagen	-$0.20	-$0.20	N/A	-$0.20	$14.55 million	$15.50 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
CORBF Global Cord Blood	N/A	N/A	N/A	N/A	N/A
DVCR Diversicare Healthcare Services	N/A	N/A	N/A	N/A	N/A
VMD Viemed Healthcare	N/A	N/A	N/A	N/A	N/A
XGN Exagen	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CORBF Global Cord Blood	N/A	N/A	N/A
DVCR Diversicare Healthcare Services	N/A	0.83	0.83
VMD Viemed Healthcare	0.02	1.48	1.37
XGN Exagen	1.06	4.95	4.95

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CORBF Global Cord Blood	N/A
DVCR Diversicare Healthcare Services	33.14%
VMD Viemed Healthcare	74.24%
XGN Exagen	75.25%

Insider Ownership

Company	Insider Ownership
CORBF Global Cord Blood	0.50%
DVCR Diversicare Healthcare Services	34.30%
VMD Viemed Healthcare	20.00%
XGN Exagen	12.60%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CORBF Global Cord Blood	1,200	121.55 million	N/A	Not Optionable
DVCR Diversicare Healthcare Services	6,000	6.95 million	4.57 million	Not Optionable
VMD Viemed Healthcare	1,179	38.79 million	31.03 million	Not Optionable
XGN Exagen	220	22.00 million	19.23 million	Optionable

DVCR, VMD, XGN, and CORBF Headlines

Recent News About These Companies

Exagen Inc. to Participate in Third Quarter Investor Conferences

August 6, 2025 | gurufocus.com

Exagen Inc. to Participate in Third Quarter Investor Conferences

August 6, 2025 | globenewswire.com

Exagen Inc. (NASDAQ:XGN) Short Interest Up 144.8% in July

August 4, 2025 | marketbeat.com

BTIG Sticks to Their Buy Rating for Exagen (XGN)

August 2, 2025 | theglobeandmail.com

FY2026 EPS Estimates for Exagen Cut by Cantor Fitzgerald

August 2, 2025 | marketbeat.com

William Blair Has Negative Outlook of Exagen FY2025 Earnings

August 2, 2025 | marketbeat.com

What is KeyCorp's Forecast for Exagen Q3 Earnings?

August 2, 2025 | marketbeat.com

FY2025 Earnings Forecast for Exagen Issued By William Blair

August 2, 2025 | americanbankingnews.com

KeyCorp Predicts Exagen's Q3 Earnings (NASDAQ:XGN)

August 2, 2025 | americanbankingnews.com

Exagen (XGN) Receives a Buy from Craig-Hallum

August 1, 2025 | theglobeandmail.com

FY2026 Earnings Forecast for Exagen Issued By KeyCorp

August 1, 2025 | marketbeat.com

Exagen Inc. Reports Record Revenue Amidst Growth Challenges

August 1, 2025 | theglobeandmail.com

Canaccord Genuity Sticks to Its Buy Rating for Exagen (XGN)

July 31, 2025 | theglobeandmail.com

Exagen (NASDAQ:XGN) Stock Price Expected to Rise, Canaccord Genuity Group Analyst Says

July 31, 2025 | marketbeat.com

Exagen (NASDAQ:XGN) Upgraded to "Overweight" at KeyCorp

July 31, 2025 | marketbeat.com

XGN | Exagen Inc. Annual Cash Flow Statement | MarketWatch

July 31, 2025 | marketwatch.com

Keybanc Upgrades Exagen (XGN)

July 31, 2025 | msn.com

Exagen (NASDAQ:XGN) Posts Earnings Results, Hits Estimates

July 30, 2025 | marketbeat.com

Exagen upgraded to Overweight from Sector Weight at KeyBanc

July 30, 2025 | msn.com

Exagen Q2 Revenue Jumps 14 Percent

July 29, 2025 | aol.comA

Exagen Inc. (XGN) Q2 2025 Earnings Call Transcript

July 29, 2025 | seekingalpha.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

DVCR, VMD, XGN, and CORBF Company Descriptions

Global Cord Blood NYSE:CORBF

$0.55 -0.80 (-59.26%)

As of 10:25 AM Eastern

Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2022, it operated three cord blood banks, including one in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation operates as a subsidiary of Blue Ocean Structure Investment Company Ltd.

Diversicare Healthcare Services OTCMKTS:DVCR

$10.09 +0.10 (+1.00%)

As of 11/22/2021

Diversicare Healthcare Services, Inc. provides post-acute care services. The firm offers services to patients and residents including skilled nursing, ancillary health care services and assisted living. It also provides long-term care centres and rehabilitative, nutritional, respiratory and other specialized ancillary services. The company was founded in 1994 and is headquartered in Brentwood, TN.

Viemed Healthcare NASDAQ:VMD

$7.42 +0.13 (+1.78%)

As of 03:17 PM Eastern

Viemed Healthcare, Inc., together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. The company leases non-invasive and invasive ventilators, positive airway pressure machines (PAP), durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment; and sells and rents HME devices. In addition, it provides neuromuscular care and oxygen therapy services; and sleep apnea management provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.

Exagen NASDAQ:XGN

$9.46 +0.08 (+0.85%)

As of 03:17 PM Eastern

Exagen Inc. develops and commercializes various testing products under the AVISE brand in the United States. The company enables healthcare providers to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). Its lead testing product is AVISE CTD that enables differential diagnosis for patients presenting with symptoms indicative of various connective tissue diseases (CTDs) and other related diseases with overlapping symptoms. The company offers AVISE Lupus that measures activation of the complement system by quantifying the level of B-cell C4d and erythrocyte bound C4d in the patient's blood; and AVISE APS, which consists of a panel of autoantibody tests that aids in the diagnosis and management of APS. In addition, it provides AVISE Vasculitis AAV, which utilizes a testing panel of individual analytes to provide physicians with results in the assessment and monitoring of anti-neutrophil cytoplasmic antibody associated vasculitis; AVISE SLE Prognostic, a panel of autoantibodies for assessing the potential for complications affecting the kidney, brain, and cardiovascular system; and AVISE Anti-CarP test, which identifies RA patients with severe disease. Further, the company offers AVISE SLE Monitor, a biomarker blood test; AVISE MTX, a patented and validated blood test; and AVISE HCQ, a blood test to monitor levels of hydroxychloroquine. It has a research collaboration and license agreement with Allegheny Health Network (AHN) Research Institute to develop novel patented biomarkers. The company was formerly known as Exagen Diagnostics, Inc. and changed its name to Exagen Inc. in January 2019. Exagen Inc. was incorporated in 2002 and is headquartered in Vista, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time